Llwytho...
PATHOGENETIC MECHANISMS OF ACTION OF STRUCTURAL MODIFIED PROLONGED ACTION ANTI-INFLAMMATORY DRUGS (SYSADOA)
The article is devoted to the combined indication of chondroitin drugs – Arthradol and glucosamine – ArthraCam in therapy of ostheoorthrosis. A symptom-modifying effect in monotherapy and in course therapy by Arthradol and ArthroCam on the background of non-steroid anti-inflammatory drugs.
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
Remedium Group LLC
2017-07-01
|
| Cyfres: | Медицинский совет |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.med-sovet.pro/jour/article/view/1930 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|